2024
Integration of Palliative Care into Heart Failure Care: Consensus-Based Recommendations from the Heart Failure Society of America
Chuzi S, Saylor M, Allen L, Desai A, Feder S, Goldstein N, Groninger H, Kirkpatrick J, Tulsky J, Steiner J, Lever N, Lewis E, Rogers J, Warraich H. Integration of Palliative Care into Heart Failure Care: Consensus-Based Recommendations from the Heart Failure Society of America. Journal Of Cardiac Failure 2024, 31: 559-573. PMID: 39608444, DOI: 10.1016/j.cardfail.2024.10.435.Peer-Reviewed Original ResearchPalliative careSpecialty PCHF careIntegration of palliative careProvision of hospice careHeart Failure Society of AmericaIntegration of PCProvision of PCConsensus statementHeart failure careQuality of lifeFrequent hospital admissionsHospice careHospital admissionCareMultiple guidelinesHF managementHeart failureHigher mortality rateQuality measuresSignificant symptomsMortality rateSpecialtyPrimary PCCliniciansVariation in symptoms of common mental disorders in the general population during the COVID-19 pandemic: longitudinal cohort study
Saunders R, Buckman J, Suh J, Fonagy P, Pilling S, Bu F, Fancourt D. Variation in symptoms of common mental disorders in the general population during the COVID-19 pandemic: longitudinal cohort study. BJPsych Open 2024, 10: e45. PMID: 38344903, PMCID: PMC10897705, DOI: 10.1192/bjo.2024.2.Peer-Reviewed Original ResearchClinically significant symptomsSymptoms of depressionMental health servicesMental disordersTrajectory classesClinically significant symptoms of depressionSignificant symptoms of depressionClinically significant symptom levelsSignificant symptomsHigher neuroticism scoresPersonality-related characteristicsGrowth mixture modelingMental health disordersMental health diagnosesNeuroticism scoresSymptom levelsGeneral populationClinical rangeExperience depressionAnxietyHealth disordersCOVID-19 Social StudyDepressionHealth diagnosisHealth servicesLong covid and mental and physical health: A cross‐sectional study of adults in California
Mason T, Knight T, Lee R, Herzig S, Meeker D, Doctor J. Long covid and mental and physical health: A cross‐sectional study of adults in California. Public Health Challenges 2024, 3: e152. PMID: 40497072, PMCID: PMC12060760, DOI: 10.1002/puh2.152.Peer-Reviewed Original ResearchLong COVID diagnosisPain interferencePhysical healthSelf-reported long COVIDLong COVID groupLong COVIDCross-sectional study of adultsPhysical functioning problemsPhysical health challengesNegative mental healthCross-sectional studyStudy of adultsAnalysis of covariance modelPhysical functionCOVID diagnosisMental healthCOVID groupHealth challengesMethods AdultsSurvey questionsCOVID-19HealthSignificant symptomsFunctional problemsAnxiety
2022
Chronic Venous Disease of the Lower Extremities: A State-of-the Art Review
Attaran R, Carr J. Chronic Venous Disease of the Lower Extremities: A State-of-the Art Review. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 2: 100538. PMID: 39132527, PMCID: PMC11307564, DOI: 10.1016/j.jscai.2022.100538.Peer-Reviewed Original ResearchChronic venous diseaseVenous diseaseSymptomatic chronic venous diseaseAmbulatory venous hypertensionCornerstone of treatmentSaphenous vein refluxDeep vein thrombosisDeep vein obstructionSignificant cost burdenQuality of lifeHealth care systemAdvanced diseaseVenous hypertensionVenous obstructionVein obstructionVein refluxVein thrombosisSuch patientsLeg ulcersSymptom improvementCatheter techniqueFemale sexRisk factorsCompression therapySignificant symptomsPsychological Attachment Orientation and Long-Term Posttraumatic Stress Symptoms Among Family Members of ICU Patients
Zhang Q, Knies AK, Pach J, Kimbrough T, Martinez A, Juthani P, Tu S, Monin JK, Vranceanu AM, Hwang DY. Psychological Attachment Orientation and Long-Term Posttraumatic Stress Symptoms Among Family Members of ICU Patients. Critical Care Explorations 2022, 4: e0753. PMID: 36050994, PMCID: PMC9426807, DOI: 10.1097/cce.0000000000000753.Peer-Reviewed Original ResearchICU patientsPTSD symptomsICU dischargeHispanic ethnicityFamily meetingsFamily membersICU patients' family membersProspective cohort studyMultiple logistic regressionLong-term PTSD symptomsPatients' family membersHigh-risk categoryLonger-term posttraumatic stress symptomsPosttraumatic stress disorder (PTSD) symptomsNeuroscience ICUEvent Scale-RevisedCohort studyIndependent predictorsPatient characteristicsRisk factorsPatient deathUnivariate analysisPatient covariatesSignificant symptomsPsychologic outcomesRisk for PTSD symptom worsening during new PTSD treatment episode in a nationally representative sample of treatment-seeking U.S. veterans with subthreshold PTSD
Gross GM, Pietrzak RH, Hoff RA, Katz IR, Harpaz-Rotem I. Risk for PTSD symptom worsening during new PTSD treatment episode in a nationally representative sample of treatment-seeking U.S. veterans with subthreshold PTSD. Journal Of Psychiatric Research 2022, 151: 304-310. PMID: 35526446, DOI: 10.1016/j.jpsychires.2022.04.040.Peer-Reviewed Original ResearchConceptsSymptom worseningRisk factorsSubthreshold PTSDPTSD symptom clustersSymptom clustersPTSD symptomsHealth care utilizationPTSD specialty clinicPoor treatment outcomesUnited States veteransBinary logistic regressionAdjusted analysisCare utilizationTreatment episodesRepresentative sampleSpecialty clinicSignificant symptomsTreatment outcomesSignificant worseningStates veteransSubthreshold symptomsEligible veteransNew episodesOutcome assessmentDiagnostic threshold
2021
Gender Issues in Obstructive Sleep Apnea.
Geer JH, Hilbert J. Gender Issues in Obstructive Sleep Apnea. The Yale Journal Of Biology And Medicine 2021, 94: 487-496. PMID: 34602886, PMCID: PMC8461585.Peer-Reviewed Original ResearchConceptsObstructive sleep apneaSleep apneaPolysomnographic findingsMale predominanceClinical presentationDiagnostic findingsSignificant symptomsMale diseaseApneaPhysiologic statusHealth consequencesWomenSymptomsGender differencesMost studiesSociocultural factorsPathophysiologyEpidemiologyFindingsDifferencesDiseaseSubstance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies
Carr MM, Ellis JD, Saules KK, Page JL, Staples A, Ledgerwood DM. Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies. American Journal On Addictions 2021, 30: 343-350. PMID: 33783065, PMCID: PMC8243775, DOI: 10.1111/ajad.13149.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyAgonist therapySeverity of symptomsDrug useTobacco useAlcohol useOpioid use disorderPoor treatment outcomesAdverse childhood eventsBinge-eating symptomsMost patientsOutpatient clinicPsychiatric comorbiditySignificant symptomsTreatment outcomesAddictive behaviorsUse disordersPatientsNegative binomial regressionSymptomsTherapyBinge eatingHigher depressionSubstance useSeverity
2019
Anxiety in 3- to 7-year-old children with autism spectrum disorder seeking treatment for disruptive behavior
Sukhodolsky DG, Lecavalier L, Johnson C, Smith T, Swiezy N, Bearss K, Kalvin CB, Scahill L. Anxiety in 3- to 7-year-old children with autism spectrum disorder seeking treatment for disruptive behavior. Autism 2019, 24: 400-410. PMID: 31390873, PMCID: PMC6982590, DOI: 10.1177/1362361319866561.Peer-Reviewed Original ResearchConceptsAutism spectrum disorderSpectrum disorderAnxiety symptomsDisruptive behaviorParent-completed rating scaleOppositional defiant behaviorYoung childrenEarly Childhood InventorySchool-aged childrenAnxiety severity scoresChild psychiatric symptomsParent trainingDefiant behaviorOppositional behaviorBehavioral problemsSocial withdrawalPreschool childrenAnxietyIQSocial disabilityPsychiatric symptomsChildrenRating ScalePercent of childrenSignificant symptoms
2018
Indwelling Pleural Catheter Placement for Nonmalignant Pleural Effusions
Bramley K, DeBiasi E, Puchalski J. Indwelling Pleural Catheter Placement for Nonmalignant Pleural Effusions. Seminars In Respiratory And Critical Care Medicine 2018, 39: 713-719. PMID: 30641589, DOI: 10.1055/s-0038-1676648.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsNonmalignant pleural effusionsPleural effusionMedical therapyMaximal medical therapyPleural catheter placementRecurrent pleural effusionCongestive heart failureRelief of dyspneaEffective therapeutic strategyHepatic hydrothoraxHeart failurePleural catheterComorbid conditionsCatheter placementConventional therapySignificant symptomsClinical conditionsTherapeutic strategiesEffusionHigh mortalityTherapyRecent studiesDyspneaHydrothoraxMorbidity
2017
An open trial of cognitive behavioral therapy with contingency management for hoarding disorder
Worden B, Bowe W, Tolin D. An open trial of cognitive behavioral therapy with contingency management for hoarding disorder. Journal Of Obsessive-Compulsive And Related Disorders 2017, 12: 78-86. DOI: 10.1016/j.jocrd.2016.12.005.Peer-Reviewed Original ResearchCognitive behavioral therapyOpen trialContingency managementBehavioral therapyTrials of CBTCurrent open trialCognitive-behavioral group therapyAdjunctive interventionSignificant symptomsEffective treatmentCBT groupLarge effect sizesHome clutterRating ScaleClutter Image Rating ScaleTherapySubstance useSymptomsMixed effects modelsGroup therapyMost participantsTrialsPatientsSignificant reductionEffect size
2013
Vandetanib for aggressive and symptomatic medullary thyroid cancer
Deshpande H, Carling T, Khan N, Holt E. Vandetanib for aggressive and symptomatic medullary thyroid cancer. Journal Of Clinical Practice 2013, 10: 275-282. DOI: 10.2217/cpr.13.17.Peer-Reviewed Original ResearchMedullary thyroid cancerThyroid cancerSymptomatic medullary thyroid cancerMetastatic medullary thyroid cancerNew tyrosine kinase inhibitorsThyroid cancer accountsTyrosine kinase inhibitorsAggressive metastatic formsGrowth factor receptorProto-oncogene RETCancer accountsClinical trialsSignificant symptomsMetastatic formSporadic formsMalignant cellsUS FDAClinical useVandetanibKinase inhibitorsFactor receptorCancerFirst agentPhase IIDiseaseSymptom dimensions are associated with age of onset and clinical course of obsessive–compulsive disorder
Kichuk SA, Torres AR, Fontenelle LF, Rosário MC, Shavitt RG, Miguel EC, Pittenger C, Bloch MH. Symptom dimensions are associated with age of onset and clinical course of obsessive–compulsive disorder. Progress In Neuro-Psychopharmacology And Biological Psychiatry 2013, 44: 233-239. PMID: 23410525, PMCID: PMC3654083, DOI: 10.1016/j.pnpbp.2013.02.003.Peer-Reviewed Original ResearchConceptsAge of onsetClinical courseObsessive-compulsive disorderPrimary symptom dimensionsSymptom dimensionsPrimary OCD symptomsChi-square testEarly ageOCD symptom dimensionsYale-Brown ObsessiveAdult patientsComorbid ticsSignificant symptomsLarge cohortDifferent OCD symptom dimensionsHeterogeneous symptomsSymptomsCompulsive ScaleDimensional Yale-Brown ObsessiveAgeSignificant differencesOCD symptomsOnsetInconsistent results
2011
Impact of robot‐assisted radical prostatectomy on health‐related quality of life in patients with lower urinary tract symptoms
Choi E, Jeong J, Kang D, Johnson K, Ercolani M, Jang T, Lee D, Kim W, Kim I. Impact of robot‐assisted radical prostatectomy on health‐related quality of life in patients with lower urinary tract symptoms. International Journal Of Urology 2011, 18: 297-303. PMID: 21342297, DOI: 10.1111/j.1442-2042.2011.02730.x.Peer-Reviewed Original ResearchConceptsLower urinary tract symptomsRobot-assisted radical prostatectomyPreoperative lower urinary tract symptomsUrinary tract symptomsHealth-related qualityAUA-SSTract symptomsRadical prostatectomyAmerican Urologic Association symptom scoreExpanded Prostate Cancer Index CompositePostoperative health-related qualityPreoperative Sexual Health InventoryProstate Cancer Index CompositeSexual Health InventorySignificant differencesLUTS severityUrinary botherUrinary domainStorage symptomsUrinary functionSevere groupSymptom scoresCommon complaintProstate cancerSignificant symptoms
2010
Predictors of Treatment Attrition Among an Outpatient Clinic Sample of Youths With Clinically Significant Anxiety
Gonzalez A, Weersing VR, Warnick EM, Scahill LD, Woolston JL. Predictors of Treatment Attrition Among an Outpatient Clinic Sample of Youths With Clinically Significant Anxiety. Administration And Policy In Mental Health And Mental Health Services Research 2010, 38: 356-367. PMID: 20976618, PMCID: PMC3145079, DOI: 10.1007/s10488-010-0323-y.Peer-Reviewed Original ResearchConceptsOutpatient mental health clinicClinician-rated dropoutTreatment attritionComorbid depression symptomsMental health clinicsPhases of treatmentOutpatient clinic sampleClinical characteristicsComorbid depressionHealth clinicsSignificant symptomsDepression symptomsSignificant anxietyClinic sampleDepressed youthAnxious youthPsychotherapy servicesRate of attritionHigh rateSymptomsTreatmentPT definitionsEthnic minority familiesContemporary Management of Symptomatic Lumbar Disc Herniations
Jegede KA, Ndu A, Grauer JN. Contemporary Management of Symptomatic Lumbar Disc Herniations. Orthopedic Clinics Of North America 2010, 41: 217-224. PMID: 20399360, DOI: 10.1016/j.ocl.2010.01.003.Peer-Reviewed Original ResearchConceptsLumbar disc herniationSymptomatic disc herniationDisc herniationClinical presentationSurgical interventionSymptomatic lumbar disc herniationMainstay of treatmentCommon clinical entityPatient's clinical presentationMagnetic resonance imagingClinical entityAsymptomatic individualsLumbar discectomyTreatment optionsConservative measuresSignificant symptomsPhysical therapyHerniationMajor abnormalitiesResonance imagingContemporary managementSymptomsPatientsInterventionDiscectomy
1990
Opioid antagonist challenges in buprenorphine maintained patients
Kosten T, Krystal J, Charney D, Price L, Morgan C, Kleber H. Opioid antagonist challenges in buprenorphine maintained patients. Drug And Alcohol Dependence 1990, 25: 73-78. PMID: 2323312, DOI: 10.1016/0376-8716(90)90144-4.Peer-Reviewed Original ResearchConceptsSublingual buprenorphine treatmentBlood pressure increaseDouble-blind placeboOpioid withdrawal symptomsBlind placeboIntravenous naloxoneNaltrexone challengeOral naltrexoneLast doseBlood pressureBuprenorphine treatmentPlacebo substitutionMHPG levelsWithdrawal symptomsPlacebo challengeSignificant symptomsAntagonist challengeBuprenorphinePatientsPlaceboNaloxoneSymptomsNaltrexoneDoseMonths
1987
Airway responses to nitrogen dioxide in asthmatic subjects
Mohsenin V. Airway responses to nitrogen dioxide in asthmatic subjects. Journal Of Toxicology And Environmental Health 1987, 22: 371-380. PMID: 3320381, DOI: 10.1080/15287398709531080.Peer-Reviewed Original ResearchConceptsAirway reactivityVital capacityAsthmatic subjectsDouble-blind randomized fashionPartial expiratory flowSpecific airway conductanceDose of methacholineNO2 exposureFunctional residual capacityAirway conductanceAirway responsesMethacholine inhalationExpiratory volumeLung functionExpiratory flowSignificant potentiationSignificant symptomsRandomized fashionRespiratory responsesResidual capacityAsthmaticsCommon indoor air pollutantsExposureSignificant changesDifferent days
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply